Wuliangye Group Yibin Pharmaceutical Co.,Ltd is jointly owned by China Sinopharm (the greatest State-owned Key Enterprises) and Wuliangye group (the China Liquor King), holded by China Sinopharm. The company was established in 1969 and is located in Luo Long industrial zone of yibin city, and covers an total area of over 220000 square meters. The location is close to the Yangtse River, and has a quick link with convenient traffic by air and river, and has beautiful scenery. Yibin Pharmaceutical Co., Ltd is a GMP approved enterprise and mainly produced formulation of Chinese medicine, APIs, biological agents, and pharmaceutical intermediates. APIs and Intermediates are our new development direction recent years ago. With a large amount of advanced production equipments, the company has an annual total capacity of 300 tons APIs, 100 million small injections, 100 million tablets, 108 tons pills and 140 tons granules. We can expand the capacity easily according to the growing market demand. Apart from GMP approval, the company is also ISO14001 and OHSAS18001 certified. The company has good standard of production facilities, research and development capabilities in APIs and Intermediates. We welcome you to visit our factory, and hope to cooperate with the enterprise who has technology and market intelligence to seek win-win cooperation.Keoprofen; L-Ornithne L-Aspartate; Potassium Dehydroandrograpolide Succinate; 5-Azacytosine; 2-(3-benzoylphenyl) propionitrile; Andrographolide; Octreotide Acetate; Nevirapine; Trandolapri; Febuxostat; 4-Hydroxyisophthalic Acid; Diacerein; Pramipexole Dihydrochloride; Esomeprazole sodium; Capecitabine, Zoledronic acid; Moxifloxacin hydrochloride; Patassium Dehydroandrograpolide Succinate; 1,2,3-Triacetyl-5-deoxy-D-ribose; 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-D-cytidine; Andrographolide?Dehydroandrographolide Succinat;
